Boston, MANCT07166848Now EnrollingIRB Ready

Chronic Ocular Graft-versus-host Disease Clinical Trial in Boston, MA

Access cutting-edge chronic ocular graft-versus-host disease treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.

Sponsored by Zhonghui K. Luo, MD, PhD

Quick Self-Assessment

See if you qualify for this Boston location

Preparing your pre-screening questions…

Expert Care in Boston

Access chronic ocular graft-versus-host disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related chronic ocular graft-versus-host disease treatment provided free

Apply for This Boston Location

Check if you qualify for this chronic ocular graft-versus-host disease clinical trial in Boston, MA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Boston

    Convenient for MA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Boston site if eligible
  4. 4Begin participation

About This Chronic Ocular Graft-versus-host Disease Study in Boston

This trial is testing to see if electrostimulation treatment (ET) will be effective in treating those with ocular Graft vs. Host Disease.

Sponsor: Zhonghui K. Luo, MD, PhD

Who Can Participate

Inclusion Criteria

Diagnosis of chronic ocular graft vs. host disease (oGVHD) (ICCGVHD criteria probable or definite)
OSDI score of 22 or higher
NEI corneal staining score (or modified NEI score) of 2 or higher.

Exclusion Criteria

Patients with any open wound on the eyelid.
Patient with any active cornea ulcer, dacryocystitis, hordeolum, filamentary keratitis, uveitis, retinal detachment, uncontrolled glaucoma or other active pathology per PI's discretion.
Patient with a pacemaker or ICD.
Patient currently pregnant or with a potential to be pregnant during the study.
Patient undergoing any ocular surgical procedure (including intravitreal injections) within the past 3 months.
Patient undergoing any systemic surgical procedures within 2 months.
Patient undergoing any non-surgical eyelid procedure such as punctal plugs or punctal cautery within 1 month of study initiation.
Patients on cytotoxic agents, drugs that inhibit peripheral nerve regeneration (i.e. Gabapentin, Nicotine), radiation therapy, or any other therapy per PI's discretion.
Patients undergoing immunosuppression regimen change within 1 month of study initiation and/or during the study period.
Patient who wears contact lens of any kind

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Boston?

Yes, this clinical trial (NCT07166848) has an active research site in Boston, MA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Chronic Ocular Graft-versus-host Disease Treatment Options in Boston, MA

If you're searching for chronic ocular graft-versus-host disease treatment options in Boston, MA, this clinical trial (NCT07166848) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic ocular graft-versus-host disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all chronic ocular graft-versus-host disease clinical trials near you to find additional studies recruiting in your area.

More Atrial Fibrillation Trials in Boston, MA

See all atrial fibrillation clinical trials recruiting in Boston — not just this study.

Browse Atrial Fibrillation Trials in Boston →

Browse More Trials by Condition

Atrial Fibrillation TrialsRheumatoid Arthritis TrialsAnkylosing Spondylitis TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Boston?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Boston, MA